Literature DB >> 10598665

Juvenile myelomonocytic leukemia and Noonan syndrome.

K Choong1, M H Freedman, D Chitayat, E N Kelly, G Taylor, A Zipursky.   

Abstract

A case of juvenile myelomonocytic leukemia (JMML, previously referred to as JCML) in a neonate with Noonan syndrome (NS) is described. The boy presented with bilateral congenital hydrothoraces, nonimmune hydrops, dysmorphic facies, persistent thrombocytopenia, and leukocytosis. The diagnosis of JMML was made on bone marrow cell culture studies. Review of the literature reveals an unusual preponderance of hematologic malignancies, in particular JMML, among patients with NS. Of 40 NS patients admitted to the authors' institution during a 10-year period, there were 4 (10%) with evidence of a monocytic proliferation, which resolved spontaneously. The authors postulate that patients with NS may have an increased incidence of myeloproliferative disorders, which in most cases appears to be benign but may be preleukemic or even lethal.

Entities:  

Mesh:

Year:  1999        PMID: 10598665

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  36 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

2.  Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.

Authors:  Rebecca J Chan; Todd Cooper; Christian P Kratz; Brian Weiss; Mignon L Loh
Journal:  Leuk Res       Date:  2008-10-26       Impact factor: 3.156

3.  Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.

Authors:  Peng-Chieh Chen; Hiroko Wakimoto; David Conner; Toshiyuki Araki; Tao Yuan; Amy Roberts; Christine E Seidman; Roderick Bronson; Benjamin G Neel; Jonathan G Seidman; Raju Kucherlapati
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

4.  Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation.

Authors:  Christian Peter Kratz; Michaela Nathrath; Peter Freisinger; Petra Dressel; Hans-Peter Assmuss; Cornelia Klein; Ayami Yoshimi; Stefan Burdach; Charlotte Marie Niemeyer
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

5.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

6.  Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals.

Authors:  Helen He Zhu; Xiaolin Luo; Kaiqing Zhang; Jian Cui; Huifang Zhao; Zhongzhong Ji; Zhicheng Zhou; Jufang Yao; Lifan Zeng; Kaihong Ji; Wei-Qiang Gao; Zhong-Yin Zhang; Gen-Sheng Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

7.  Severe congenital thrombocytopaenia--first clinical manifestation of Noonan syndrome.

Authors:  Paula Nunes; Sara Aguilar; Sara Noéme Prado; Maria João Palaré; Anabela Ferrão; Anabela Morais
Journal:  BMJ Case Rep       Date:  2012-03-20

8.  Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.

Authors:  Tetsuya Niihori; Yoko Aoki; Hirofumi Ohashi; Kenji Kurosawa; Tatsuro Kondoh; Satoshi Ishikiriyama; Hiroshi Kawame; Hotaka Kamasaki; Tsutomu Yamanaka; Fumio Takada; Kimio Nishio; Masahiro Sakurai; Hiroshi Tamai; Tatsuro Nagashima; Yoichi Suzuki; Shigeo Kure; Kunihiro Fujii; Masue Imaizumi; Yoichi Matsubara
Journal:  J Hum Genet       Date:  2005-04-15       Impact factor: 3.172

9.  Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.

Authors:  Suzanne Schubbert; Kenneth Lieuw; Sara L Rowe; Connie M Lee; Xiaxin Li; Mignon L Loh; D Wade Clapp; Kevin M Shannon
Journal:  Blood       Date:  2005-03-10       Impact factor: 22.113

Review 10.  Haematology of Down syndrome.

Authors:  David Webb; Irene Roberts; Paresh Vyas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09-05       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.